Oligonucleotide Pool Market Overview, Opportunities, Profile and Global Industry Analysis To 2027
Global
Oligonucleotide Pool Market Research Report: Information by Type (DNA and RNA),
Application (Research, Diagnostics & Therapeutics and other), End User
(Commercial Research, Pure Academic Research and other) and Region (North
America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till
2027
Oligonucleotide Pool Market Highlights
It has been noted that global oligonucleotide pool market is
growing at moderate pace and is expected to grow at the CAGR of 8.5%.
Oligonucleotide pool market is driven by three major factors such as huge
investments from big pharmaceutical companies in oligonucleotide therapeutics
for drug development, CMO’s involvement in manufacturing therapeutic
oligonucleotides and wide application areas offered by the oligonucleotides.
There are only small number of
approved oligonucleotide drugs available in the market. Currently there are
only three drugs available in the U.S. Having said that, according to Nitto
Denko Avecia internal research, nearly 116 oligonucleotides were in active
clinical trials as of August 2015. Very few of the oligonucleotide drug
sponsors have their own in-house cGMP manufacturing facilities. On the other
hand, more than half of the oligonucleotides in the clinical development stage
are manufactured by the contract manufacturing organizations (CMO). As more
number of oligonucleotides are on the verge of regulatory approval, the demand
for such oligonucleotides will increase in the market. The increased demand is
likely to force the CMO’s to increase their capacity and improve efficiency in
manufacturing the oligonucleotides. CMO’s are adopting different strategies to
increase the manufacturing capacity. For example, in 2014, German CMO BioSpring
added a midscale synthesizer to increase the capacity. Nitto Denko Avecia, the
leading CMO has implemented the use of thin film evaporation in order to
concentrate product solutions prior to lyophilisation which results in larger
final batches of custom oligos. The increasing involvement of the CMOs in order
to cater to the demand of oligonucleotides is likely to boost the growth of the
oligonucleotide pool market.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/2556
Global
Oligonucleotide Pool Market - Competitive Analysis
February, 2017 - Integrated DNA
Technologies, Inc. had announced the acquisition of oligo manufacturing
business of GeneWorks (Australia). This acquisition by the company enhances the
capacity for direct sales of genomic products in Asia-Pacific region.
Integrated DNA Technologies, Inc. (IDT) is one of the leading biotechnology
company that is involved in manufacturing, developing nucleic acid products for
the life sciences industry. The company mainly sells and distributes short
strands of DNA called oligonucleotides. The company’s essential business is the
creation of custom oligonucleotides for molecular biology applications. IDT has
created restrictive innovations for genomics applications, which include
generation sequencing, CRISPR genome editing, qPCR, and RNA interference. The
products offered by the company serves many of the small university academic
research, biotechnology, clinical diagnostics, and pharmaceutical development
all around the world. The company is specialized in Custom Oligonucleotides,
DNA Synthesis, Synthetic Biology, RNA Synthesis, Synthesis Reagents, Next
generation sequencing, Nucleic Acid Synthesis,
Genes & gene fragments,
Primers, GMP Manufacturing, Genotyping, Probes, RNAi, qPCR, and CRISPR genome
editing.
December, 2016 – Agilent
Company announced the acquisition of Multiplicom N.V., a Leading European
Diagnostics Company. On this acquisition Herman Verrelst, vice president said
“The acquisition of Multiplicom significantly strengthens our presence in the
genomics market". Agilent is one of the leaders in life sciences,
diagnostics and applied chemical markets. The company provides services to
laboratories all around the world with its instruments, services, consumables,
applications and expertise. Agilent mainly focuses on six major industries
which involve food, environmental and forensics, pharmaceutical, diagnostics,
chemical and energy and research. The company with its three brands CrossLab
combines, Dako Agilent Pathology Solutions and Agilent OpenLAB Software Suite
is innovating and providing special services to laboratories with high
technology.
Global
Oligonucleotide Pool Market - Regional
Analysis
As per Market Research Future
analysis, the global oligonucleotide pool market has grown tremendously in
Asia-Pacific. Geographically, North America holds the largest share of more
than 42.2% of oligonucleotide pool market and is expected to be the leading
market during 2016-2022. The major factor that influences the growth of the
North American oligonucleotide pool market is the existence of large number of
small scale and big scale manufacturers of oligonucleotide pool and service
providers in the region.
After North America region,
Europe market is the second largest market in the global oligonucleotide pool
market. Increasing investment by organizations in the field of genomics serves
as a significant driver for this region. Whereas Asia Pacific region is
expected to be the fastest growing market due to increasing R&D funding by
the developing countries like China and India for the development of
oligonucleotide products.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/oligonucleotide-pool-market-2556
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment